News & Press Release
2017
- All Categories
- Announcements
- HR and Organization
- Product Information
-
- 2017-12-15 Product Information Marketing Approval Granted for TITANBRIDGETM First SAKIGAKE Designated Medical Device to Treat Adductor Spasmodic Dysphonia
- 2017-08-01 Announcements Our project “Malaria Vaccine Development and Establishment of its Commercial Manufacturing” selected for the Cyclic Innovation for Clinical Empowerment (CiCLE) by the Japan Agency for Medical Research and Development (AMED) in the first recruitment
- 2017-07-07 Product Information Marketing Approval Application Submitted to MHLW for NPC-17 (titanium bridge), the First Medical Device to Receive the SAKIGAKE Designation
- 2017-02-08 Announcements At the Japan Venture Awards 2017, held by Organization for Small & Medium Enterprises and Regional Innovation, Japan on February 6, 2017, the President and CEO of Nobelpharma, Mr. Jin Shiomura, has received “the Economy, Trade and Industry Minister Prize”